NHS England specialised commissioning

NHS England specialised commissioning
Name	NHS England specialised commissioning
Type	National healthcare commissioning function
Founded	2013
Jurisdiction	England
Parent organisation	NHS England
Headquarters	London

NHS England specialised commissioning is the national function within NHS England responsible for planning, funding, and overseeing high-cost, low-volume healthcare services across England. It allocates resources for treatments and services that require concentrated expertise, infrastructure, or clinical networks, coordinating with regional bodies and national partners to ensure equitable access. The programme interacts with a wide range of institutions, regulatory bodies, and clinical networks to set policy, procure specialised services, and monitor outcomes.

Overview

Specialised commissioning manages services that are clinically complex or rare, including highly specialised surgery, specialised medicines, and national screening and transplantation programmes. It operates alongside clinical commissioning bodies such as NHS Clinical Commissioning Groups and regional entities like NHS England North West, shaping national service specifications used by providers including Royal Marsden Hospital, Great Ormond Street Hospital, Guy's and St Thomas' NHS Foundation Trust, Addenbrooke's Hospital, and other specialist centres. The function aligns with regulatory frameworks established by Care Quality Commission, performance regimes informed by National Institute for Health and Care Excellence, and workforce considerations involving organisations such as Health Education England. It also engages with academic partners including University College London, University of Oxford, University of Cambridge, Imperial College London, and research funders like National Institute for Health Research.

Historical development

Specialised commissioning evolved from centrally managed services and national service frameworks dating from the 1970s and 1980s, influenced by reforms under ministers such as Kenneth Clarke, Michael Heseltine, and later health secretaries including Alan Milburn. Major reorganisations under the Health and Social Care Act 2012 and the establishment of NHS England in 2013 formalised the specialised commissioning role. Predecessor arrangements involved national specialised commissioning groups and regional centres coordinated by organisations like NHS South Central and NHS London. Subsequent policy developments including the Five Year Forward View and the NHS Long Term Plan expanded national pathways for services such as rare disease networks, paediatric services, and adult congenital heart disease, drawing on clinical reference groups with experts from institutions such as Royal Brompton Hospital and Manchester University NHS Foundation Trust.

Scope of services and eligibility

The portfolio covers a broad array of services: specialised surgery (e.g., complex orthopaedics, neurosurgery), specialised medicines including orphan drugs and biologics, rare disease diagnostics, transplantation services, specialised cancer treatments, and national screening programmes. Eligibility criteria are often defined by clinical thresholds, pathology confirmation, or genetically defined indications, and are operationalised through national tariffs and service specifications used by providers such as Royal Free London, Leeds Teaching Hospitals NHS Trust, and Newcastle upon Tyne Hospitals NHS Foundation Trust. Service pathways intersect with national public health initiatives led by Public Health England and policy guidance from Department of Health and Social Care.

Commissioning structure and governance

Governance includes national directorates, clinical reference groups, and commissioning policy fora that bring together clinicians, commissioners, and patient representatives. Decision-making interfaces with regulatory bodies including Monitor (NHS Foundation Trusts) and clinical leadership drawn from specialist centres such as St Bartholomew's Hospital and Moorfields Eye Hospital. Strategic oversight is exercised through boards and committees within NHS England that liaise with arm’s-length bodies like NHS Improvement and advisory panels from organisations such as Joint Committee on Vaccination and Immunisation where relevant. Patient advocacy groups and charities including Macmillan Cancer Support, Great Ormond Street Hospital Charity, and Muscular Dystrophy UK contribute to governance consultations.

Funding and procurement mechanisms

Funding combines block allocations, national tariffs, and specialised commissioning budgets distributed by NHS England to meet national demand. High-cost medicines and devices may be procured through national frameworks and competitive tenders involving suppliers regulated by Medicines and Healthcare products Regulatory Agency and procured via national contracting frameworks used by organisations such as Crown Commercial Service. Value assessment draws on health technology appraisal from National Institute for Health and Care Excellence and commissioning decisions reflect budget impact modelling, outcomes-based agreements, and commercial arrangements with pharmaceutical companies including multinational firms headquartered in cities such as London and Cambridge.

Performance, outcomes and accountability

Performance measurement uses outcome metrics, patient-reported outcome measures, survival data, and quality indicators monitored through surveillance systems and registries like the National Congenital Anomaly and Rare Disease Registration Service and cancer registries tied to centres such as The Christie. Accountability routes include parliamentary scrutiny via House of Commons Health and Social Care Select Committee, audit by National Audit Office, and regulatory inspection by Care Quality Commission. Data linkage and analysis involve partners like NHS Digital and academic groups at King's College London and University of Manchester to evaluate access, equity, and clinical effectiveness.

Challenges and reforms

Challenges include rising costs of orphan drugs, workforce shortages across specialist disciplines, geographic variation in access, and integration with regional care systems such as Integrated Care Systems. Reforms have targeted commissioning pathways, introduction of national service specifications, and innovative contracting like outcomes-based commissioning piloted with clinical networks from centres such as Papworth Hospital and Royal Victoria Infirmary. Policy drivers for reform appear in strategic documents from Department of Health and Social Care and initiatives allied with the NHS Long Term Plan, with ongoing debate involving stakeholders including patient organisations, professional colleges like Royal College of Physicians, and industry associations such as Association of the British Pharmaceutical Industry.

Category:National health services